1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Anticoagulant Reversal Drug Market – By Product

1.3.2        Anticoagulant Reversal Drug Market – By Distribution Channel

1.3.3        North America Anticoagulant Reversal Drug Market – By Country

2.           North America Anticoagulant Reversal Drug Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Anticoagulant Reversal Drug Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Anticoagulant Reversal Drug Market- North America PEST Analysis

4.3         Expert Opinion

5.           North America Anticoagulant Reversal Drug Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rise in Prevalence of Atrial Fibrillation (AFib)

5.1.2        Increase in Prevalence of Stroke

5.2         Market Restraints

5.2.1        High Cost of Anticoagulant Reversal Drugs

5.3         Market Opportunities

5.3.1        Increasing Research Activities on Anticoagulant Reversal Drugs

5.4         Future Trends

5.4.1        Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Anticoagulant Reversal Drug Market – North America Analysis

6.1         North America Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis

7.           North America Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 – By Product

7.1         Overview

7.2         Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

7.3         Prothrombin Complex Concentrates

7.3.1        Overview

7.3.2        Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.4         Vitamin K

7.4.1        Overview

7.4.2        Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.5         Protamine

7.5.1        Overview

7.5.2        Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.6         Tranexamic Acid

7.6.1        Overview

7.6.2        Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.7         Idarucizumab

7.7.1        Overview

7.7.2        Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

7.8         Andexxa

7.8.1        Overview

7.8.2        Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.           North America Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027– By Distribution Channel

8.1         Overview

8.2         Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

8.3         Hospital Pharmacies

8.3.1        Overview

8.3.2        Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.4         Retail Pharmacies

8.4.1        Overview

8.4.2        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

9.           Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 – Geographical Analysis

9.1         North America: Anticoagulant Reversal Drugs Market

9.1.1        Overview

9.1.2        North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

9.1.3        US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          US: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)

9.1.3.3          US: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)

9.1.4        Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Canada: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)

9.1.4.3          Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)

9.1.5        Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          Mexico: Anticoagulant Reversal Drugs Market, by Product, 2018–2027 (USD Million)

9.1.5.3          Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel 2018–2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on North America Anticoagulant Reversal Drug Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.2.2     Organic Developments Done By Companies

11.3      Inorganic Developments

11.3.1     Overview

11.3.2     Inorganic Developments Done By Companies

Source: The Insight Partners Analysis, Website, Press Releases and Others

12.        COMPANY PROFILES

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Pfizer Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Octapharma AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      AMAG PHARMACEUTICALS, INC.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Fresenius Kabi AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6       Key Developments

12.6      Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      CSL Limited

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Grifols, S.A.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About the Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             US Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 3.             Canada Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.             Canada Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             Mexico Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             Mexico Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             Glossary of Terms, Anticoagulant Reversal Drug Market

LIST OF FIGURES

Figure 1.           Anticoagulant Reversal Drug Market Segmentation

Figure 2.           North America Anticoagulant Reversal Drug Market Overview

Figure 3.           Vitamin K Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market

Figure 4.           Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Anticoagulant Reversal Drug Market - North America PEST Analysis

Figure 7.           Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints

Figure 8.           North America Anticoagulant Reversal Drug Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 1.           Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)

Figure 2.           Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 3.           Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 4.           Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 5.           Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 6.           Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 7.           Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 8.           Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 9.           Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 10.        Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 11.        Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)

Figure 12.        North America: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)

Figure 13.        North America: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)

Figure 14.        US: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 15.        Canada: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 16.        Mexico: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 17.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 18.        Growth Strategies Done by the Companies in the Market, (%)